| Detection of cancer DNA in plasma of patients with early-stage breast cancer JA Beaver, D Jelovac, S Balukrishna, RL Cochran, S Croessmann, ... Clinical cancer research 20 (10), 2643-2650, 2014 | 430 | 2014 |
| Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells H Konishi, M Mohseni, A Tamaki, JP Garay, S Croessmann, S Karnan, ... Proceedings of the National Academy of Sciences 108 (43), 17773-17778, 2011 | 206 | 2011 |
| ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients D Chu, C Paoletti, C Gersch, DA VanDenBerg, DJ Zabransky, ... Clinical cancer research 22 (4), 993-999, 2016 | 184 | 2016 |
| Ki-67 is required for maintenance of cancer stem cells but not cell proliferation J Cidado, HY Wong, DM Rosen, A Cimino-Mathews, JP Garay, ... Oncotarget 7 (5), 6281, 2016 | 104 | 2016 |
| Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA PV Toro, B Erlanger, JA Beaver, RL Cochran, DA VanDenBerg, E Yakim, ... Clinical biochemistry 48 (15), 993-998, 2015 | 97 | 2015 |
| HER2 missense mutations have distinct effects on oncogenic signaling and migration DJ Zabransky, CL Yankaskas, RL Cochran, HY Wong, S Croessmann, ... Proceedings of the National Academy of Sciences 112 (45), E6205-E6214, 2015 | 92 | 2015 |
| MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers M Mohseni, J Cidado, S Croessmann, K Cravero, A Cimino-Mathews, ... Proceedings of the National Academy of Sciences 111 (49), 17606-17611, 2014 | 78 | 2014 |
| The role of targeted therapy and biomarkers in breast cancer treatment AT Stopeck, U Brown-Glaberman, HY Wong, BH Park, SE Barnato, ... Clinical & experimental metastasis 29, 807-819, 2012 | 51 | 2012 |
| Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation GM Wang, HY Wong, H Konishi, BG Blair, AM Abukhdeir, JP Gustin, ... Cancer research 73 (11), 3248-3261, 2013 | 46 | 2013 |
| TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer HY Wong, GM Wang, S Croessmann, DJ Zabransky, D Chu, JP Garay, ... Oncotarget 6 (42), 44927, 2015 | 43 | 2015 |
| Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease HY Wong, Q Sheng, AB Hesterberg, S Croessmann, BL Rios, K Giri, ... Nature Communications 13 (1), 6036, 2022 | 36 | 2022 |
| NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability S Croessmann, HY Wong, DJ Zabransky, D Chu, J Mendonca, A Sharma, ... Proceedings of the National Academy of Sciences 112 (37), 11583-11588, 2015 | 32 | 2015 |
| PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity S Croessmann, HY Wong, DJ Zabransky, D Chu, DM Rosen, J Cidado, ... Breast cancer research and treatment 162, 451-464, 2017 | 27 | 2017 |
| Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reaction RL Cochran, K Cravero, D Chu, B Erlanger, PV Toro, JA Beaver, ... Human pathology 45 (7), 1546-1550, 2014 | 17 | 2014 |
| A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers D Jelovac, JA Beaver, S Balukrishna, HY Wong, PV Toro, ... Human pathology 45 (4), 880-883, 2014 | 17 | 2014 |
| A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations BG Blair, X Wu, MS Zahari, M Mohseni, J Cidado, HY Wong, JA Beaver, ... Proteomics 15 (2-3), 318-326, 2015 | 15 | 2015 |
| A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer AB Hesterberg, BL Rios, EM Wolf, C Tubbs, HY Wong, KR Schaffer, ... The Journal of Pathology: Clinical Research 7 (3), 271-286, 2021 | 13 | 2021 |
| Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones S Karthikeyan, IG Waters, L Dennison, D Chu, J Donaldson, DH Shin, ... The Journal of Clinical Investigation 131 (6), 2021 | 13 | 2021 |
| Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes RL Cochran, J Cidado, M Kim, DJ Zabransky, S Croessmann, D Chu, ... Oncotarget 6 (28), 25240, 2015 | 11 | 2015 |
| PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells MJ Higgins, JA Beaver, HY Wong, JP Gustin, JD Lauring, JP Garay, ... Cancer Biology & Therapy 11 (3), 358-367, 2011 | 9 | 2011 |
